RecruitingNCT06719583
Black and African Americans Connections to Parkinson's Disease (BLAAC PD)
Black and African Americans Connections to Parkinson's Disease (BLAAC PD) A Project of the Global Parkinson's Genetics Program (GP2)
Sponsor
Michael J. Fox Foundation for Parkinson's Research
Enrollment
2,000 participants
Start Date
Nov 16, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
BLAAC PD is a research study to understand what Parkinson's disease looks like for Black and African American communities. BLAAC PD is happening at research centers around the United States. The study is part of the Global Parkinson's Genetics Program (GP2). GP2 is a research project working to transform understanding of the genetics of Parkinson's disease and make that knowledge globally relevant.
Eligibility
Min Age: 18 Years
Inclusion Criteria7
- Ability to provide informed consent
- Age 50 years or older
- Self-identify as Black or African American
- Ability to provide informed consent
- Age 18 years or older
- Self-identify as Black or African American
- Meet the Movement Disorder Society's clinical diagnostic criteria for Parkinson's disease
Exclusion Criteria6
- Diagnosis of Parkinson's Disease and/or neurological condition
- Familial history of PD and/or neurodegenerative or psychiatric conditions
- Unknown family history of PD and/or neurodegenerative or psychiatric conditions
- Any conditions that, in the investigator's opinion, preclude the individual's ability to carry out study activities
- If submitting a saliva sample, nothing by mouth (food, drink, gum, tobacco, or smoking) for 30 minutes prior to sample collection
- \- If submitting a saliva sample, nothing by mouth (food, drink, gum, tobacco, or smoking) for 30 minutes prior to sample collection
Locations(12)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06719583
Related Trials
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
NCT0447778550 locations
Vestibular and Cortical Contributions to Transitions in Freezing of Gait in Parkinson's Disease
NCT065060581 location
Cerebellar Stimulation and Cognitive Control
NCT032171101 location
Characterizing the Pathophysiological Role of the Pallido-thalamocortical Motor Pathway in Parkinson's Disease.
NCT066929201 location
Cue2Walk, Cost-effectiveness of Automated Freezing Detection and Provision of External Cues in Comparison to Usual Care in People With Parkinson's Disease
NCT064163452 locations